Science Market Update

UC Davis: Major Cancer Research Funding Awarded by NCI

Posted by Rebecca Inch-Partridge on Thu, Sep 13, 2018

UC Davis Medical Center is home to one of only 49 National Cancer Institute (NCI) designated comprehensive cancer centers. The UC Davis Center is the only comprehensive cancer center in California’s Central Valley and inland northern California. It serves a region with a population of roughly 6 million people. The Center has $63 million in NHI and California Healthcare Institute funding.  

The NCI, a division of the NIH, awards University of California, Davis roughly $200 million annually to conduct cancer research.  

Here are the top 5 NCI grants this year:

Read More

Tags: CA, University of California Davis Medical Center, Southwest, NIH funded Research Projects, UCDMC, BioResearch Product Faire Event, biotech vendor show, Sacramento, cancer research funding, Comprehensive Cancer Center, Oncology, Cancer Immunotherapy, Cancer Science

$150M Gift to Advance Cancer Research and Care at University of Michigan

Posted by Rebecca Inch-Partridge on Mon, Apr 30, 2018

Richard and Susan Rogal recently committed $150,000,000 to the University of Michigan Comprehensive Cancer Center. It is the largest gift ever been made to Michigan Medicine. The money will be used to support promising cancer research and help train the next generation of researchers.

Read More

Tags: University of Michigan, new research funding, University Research, Michigan, University of Michigan Ann Arbor, MI, laboratory equipment suppliers, UMich, Midwest Region, research news, cancer research funding, cancer research grant, BioResearch Product Faire, cancer reserach, NIH awards 2017, 2017 research funding, University of Michigan research, university research funding

Proctor & Gamble to Give $10 Million to Cincinnati Cancer Center

Posted by Rebecca Inch-Partridge on Tue, Apr 10, 2018

Proctor & Gamble will give to give $10 Million to support research and outcomes at Cincinnati Cancer Center (CCC), a collaboration of the University of Cincinnati (UC), UC Health, and Cincinnati Children’s Hospital. The gift will fund recruitment and research enhancements that will assist with the center’s pursuit of achieving the designation of Comprehensive Cancer Center from the National Center Institute.

Read More

Tags: University of Cincinnati, BioResearch Product Faire Event, Cincinnati, OH, laboratory equipment, laboratory equipment suppliers, UCinci, lab suppliers, laboratory equipment sales, cancer research funding, BioResearch Product Faire, Comprehensive Cancer Center

UCSD Scientists Receive $8M to Research Leukemia Treatments

Posted by Laura Braden on Tue, Jan 02, 2018

Of the four main types of Leukemia, Acute Myeloid Leukemia (AML) diagnoses make up nearly one-third of new leukemia cases and is most likely to occur in adults. Although common cancer treatment methods are used for AML patients, only about half go into remission after chemotherapy treatments. Factors such as age and overall health contribute to these remission rates. Researchers at top life science institutions around the world continually study AML to gain better understandings of the biology of this cancer that can lead to new and more effect treatment methods. (Image courtesy Wikimedia Commons)

Read More

Tags: CA, Leukemia, new research funding, cancer research, San Diego, SDVS, UCSD, Biotechnology Vendor Showcase, cancer research funding, 2018, AML Research, Acute Myeloid Leukemia

Texas Researchers Receive $5.7M to Further Cancer Research

Posted by Laura Braden on Thu, Dec 14, 2017

 The state of Texas is striving to increase cancer research capabilities and opportunities with the Cancer Prevention and Research Institute of Texas (CPRIT). One method that CPRIT uses to increase cancer research opportunities throughout the state is through the institutes core facility support awards, which provide more funding and opportunities for researchers from different Texas institutions. Recently, researchers from Texas A&M University received a $5.7 million grant from CPRIT to expand cancer research at the university through this additional core facility funding. (Image courtesy of Aggie0083 via Wikimedia Commons)

Read More

Tags: Texas A&M University, Texas Medical Center, Texas, TAMU, tmc, BioResearch Product Faire Event, Houston, TX, cancer research funding, 2018, Baylor College of Medicine, core facility funding

Washington University, St. Louis: $6 Million in Leukemia Research Funding

Posted by Rebecca Inch-Partridge on Thu, Dec 07, 2017

According to the National Cancer Institute (NCI) there are over 380,000 people living with leukemia in the United States. Each year roughly 24,500 people die from the disease and over 62,000 new cases are diagnosed. To improve treatment options for leukemia patients, the NCI recently awarded John DiPersio, MD, PhD of Washington University, St. Louis $6 million in research funding. The Professor of Medicine in Oncology at the university’s School of Medicine will use the seven years of funding to support three major areas of leukemia research in his lab. These include: improving the effectiveness of standard chemotherapy, preventing graft-versus-host disease, and developing new immunotherapies.

Read More

Tags: Washington University St. Louis, Washington University, WashU, WUSTL, Leukemia, cancer research, Cancer, Research Funding, biotech vendor show, cancer research funding, Bioresearch Grant, Biotechnology trade show, NIH awards 2017, Cancer Therapeutics, Cancer Immunotherapy

Jefferson U: Donations & NIH Funding Yields New Approaches to Treating Cancer

Posted by Rebecca Inch-Partridge on Tue, Nov 14, 2017

Each year, The Sidney Kimmel Cancer Center (SKCC) at Jefferson University Hospital receives approximately $72 million in grants for cancer research from organizations such as Susan Komen for the Cure. This year the SKCC received a $3 million donation from Esperanza and David Neu in order to establish the Neu Center for Supportive Medicine and Cancer Survivorship. The purpose of the Neu Center is to serve as a comprehensive resource for psycho-social care and research.

Read More

Tags: Pennsylvania, Northeast, Thomas Jefferson University, cancer research, NIH funded Research Projects, Philadelphia, PA, NIH funding, Cancer Center, ThomJeff, cancer research funding, BioResearch Product Faire, NIH awards 2017, 2017 research funding

UMinn: Top Funded Research Projects Right Now

Posted by BCI Staff on Fri, Oct 27, 2017

The University of Minnesota is one of the top research universities globally. Year after year, research programs continue to grow as the University attracts top scientists, to enjoy the academic and cultural setting that is offered on the Twin Cities Campus.

Read More

Tags: University of Minnesota, cancer research, Minnesota, University of Minnesota Twin Cities, Research Funding, MN, UMinn, Midwest Region, new research grant, cancer research funding

Fred Hutch: $7M in Research Funding for Study of Second Primary Breast Cancer

Posted by Rebecca Partridge on Wed, Aug 16, 2017

Between 3 to 20 percent of women with breast cancer will develop another primary cancer tumor in the opposite breast within ten years of the first diagnosis. Though previous studies have identified some environmental, genetic, and treatment-related risk factors for contralateral breast cancer, scientists still don’t fully understand what causes these second primary cancers.

Read More

Tags: Fred Hutchinson Cancer Research Center, breast cancer, Research Funding, Hutch, Cancer Center, cancer research funding, laboratory suppliers, Fred Hutch, BioResearch Product Faire, Biotechnology trade show, 2017 research funding

Fred Hutch Receives $6.4M in Research Funding to Improve Heart Health of Cancer Survivors

Posted by Rebecca Partridge on Tue, Jun 27, 2017

 In March, the National Cancer Institute (NCI) approved a $3.7 million, five-year grant to extend Dr. Eric Chow’s research into improving treatment of cardiovascular risk factors in childhood cancer survivors. Dr. Chow is a clinical researcher, epidemiologist, and pediatric oncologist at Fred Hutchinson Cancer Research Center in Seattle, Washington. This is one of two research grants to be awarded to Dr. Chow by the National Cancer Institute. The NCI also chose to extend Dr. Chow’s study of the long-term efficacy of a medication meant to minimize or prevent heart injury in pediatric patients going through chemotherapy. This $2.7 million in research funding will allow for four more years of studies regarding the use of dexrazoxane in pediatric cancer patients. 

Read More

Tags: Fred Hutchinson Cancer Research Center, Pediatric Cancer Research, Research Funding, Hutch, Cancer Center, cancer research funding, laboratory suppliers, Fred Hutch, BioResearch Product Faire, Biotechnology trade show, general lab supply, 2017 research funding

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News